- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Biomimetic Liposomal Nanoplatinum for Targeted Cancer Chemophototherapy ; year:2021
Advanced science ; (2021)
- Creator
-
Liu, Xue‐Liang
Dong, Xiao
Yang, Si‐Cong
Lai, Xing
Liu, Hai‐Jun
Gao, Yuhao
Feng, Hai‐Yi
Zhu, Mao‐Hua
Yuan, Yihang
Lu, Qin
Lovell, Jonathan F.
Chen, Hong‐Zhuan
Fang, Chao
- DOI
-
10.1002/advs.202003679
- URN
-
urn:nbn:de:101:1-2021030412194538903610
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Liu, Xue‐Liang
- Dong, Xiao
- Yang, Si‐Cong
- Lai, Xing
- Liu, Hai‐Jun
- Gao, Yuhao
- Feng, Hai‐Yi
- Zhu, Mao‐Hua
- Yuan, Yihang
- Lu, Qin
- Lovell, Jonathan F.
- Chen, Hong‐Zhuan
- Fang, Chao
Other Objects (12)
Biomimetic liposomal nanozymes improve breast cancer chemotherapy with enhanced penetration and alleviated hypoxia
Biomimetic nanobubbles for triple-negative breast cancer targeted ultrasound molecular imaging
Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug delivery
Engineered extracellular vesicles-like biomimetic nanoparticles as an emerging platform for targeted cancer therapy
Biomimetic nanoparticle-driven strategies for targeted drug delivery in glioblastoma
Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
Irisin‐Encapsulated Mitochondria‐Targeted Biomimetic Nanotherapeutics for Alleviating Acute Kidney Injury
Liposomal drug carrier systems for inhalation treatment of lung cancer
Liposomal drug carrier systems for inhalation treatment of lung cancer
Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy
Targeted delivery of bee venom to A549 lung cancer cells by PEGylate liposomal formulation: an apoptotic investigation
Biomimetic liposomal nanozymes improve breast cancer chemotherapy with enhanced penetration and alleviated hypoxia
Biomimetic nanobubbles for triple-negative breast cancer targeted ultrasound molecular imaging
Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug delivery
Engineered extracellular vesicles-like biomimetic nanoparticles as an emerging platform for targeted cancer therapy
Biomimetic nanoparticle-driven strategies for targeted drug delivery in glioblastoma
Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
Irisin‐Encapsulated Mitochondria‐Targeted Biomimetic Nanotherapeutics for Alleviating Acute Kidney Injury
Liposomal drug carrier systems for inhalation treatment of lung cancer
Liposomal drug carrier systems for inhalation treatment of lung cancer
Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy
Targeted delivery of bee venom to A549 lung cancer cells by PEGylate liposomal formulation: an apoptotic investigation
Biomimetic liposomal nanozymes improve breast cancer chemotherapy with enhanced penetration and alleviated hypoxia
Biomimetic nanobubbles for triple-negative breast cancer targeted ultrasound molecular imaging
Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug delivery
Engineered extracellular vesicles-like biomimetic nanoparticles as an emerging platform for targeted cancer therapy
Biomimetic nanoparticle-driven strategies for targeted drug delivery in glioblastoma
Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
Irisin‐Encapsulated Mitochondria‐Targeted Biomimetic Nanotherapeutics for Alleviating Acute Kidney Injury
Liposomal drug carrier systems for inhalation treatment of lung cancer
Liposomal drug carrier systems for inhalation treatment of lung cancer
Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy